Synapsoft logo
AI Insights from Disclosures
Searching...
SAMJIN PHARMACEUTICAL CO.,LTD 005500
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
SAMJIN PHARMACEUTICAL CO.,LTD has built competitiveness in the pharmaceutical market through a wide portfolio ranging from over-the-counter drugs trusted by consumers, to prescription drugs across various treatment areas, and active pharmaceutical ingredients backed by precise technology, and aims to develop excellent medicines through new drug research and development based on its unrivaled technology. Its main over-the-counter products, aimed at improving patients' quality of life, include the anti-inflammatory analgesic 'Geborin (tablets)' and the appetite stimulant 'Trestan (capsules)'; and its prescription drugs for treating chronic diseases increasing with an aging society include the antiplatelet agent 'Plaris (tablets)' and the brain function improving agent 'Nutirin (capsules)'.
Representative Director Choi Jihyeon, Cho Gyuseok
Founded April 18, 1968
Corporation Type KOSPI
Industry Classification Manufacture of medicaments
Corporate number 11011-0088652
Business number 105-81-00769
Phone Number 02-3140-0700
Fax Number 02-392-5312
Company Address 121 Wausan-ro, Mapo-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant